BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4347920)

  • 1. Problems peculiar to brain malignancies.
    Ramamurthi B
    Indian J Cancer; 1972 Sep; 9(3):249-50. PubMed ID: 4347920
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccine for aggressive brain tumors may prolong survival.
    Health News; 2004 Dec; 10(12):7. PubMed ID: 15645564
    [No Abstract]   [Full Text] [Related]  

  • 3. [Value of immunologic studies in malignant tumors of the human brain].
    Romodanov AP; Lisianyĭ NI; Prikhodchenko IA
    Zh Vopr Neirokhir Im N N Burdenko; 1983; (3):56-9. PubMed ID: 6310917
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunology and immunotherapy of cerebral tumors. Current status].
    Trouillas P
    Rev Neurol (Paris); 1973 Jan; 128(1):23-38. PubMed ID: 4367367
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cellular immunotherapy of cerebral glioblastoma. Apropos of 2 results].
    Trouillas P; Lapras C
    J Med Lyon; 1969 Oct; 50(172):1269-91. PubMed ID: 4320802
    [No Abstract]   [Full Text] [Related]  

  • 6. [Adoptive immunotherapy in glioblastoma multiforme: experience with the use of intrathecal infusions of autologous leukocytes].
    Vaquero J; Martínez R; de Haro J; Barbolla L; Salazar J; Santos H
    Arch Neurobiol (Madr); 1987; 50(3):183-90. PubMed ID: 3039937
    [No Abstract]   [Full Text] [Related]  

  • 7. Glioblastoma-derived mechanisms of systemic immunosuppression.
    Waziri A
    Neurosurg Clin N Am; 2010 Jan; 21(1):31-42. PubMed ID: 19944964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current concepts and management of glioblastoma.
    Preusser M; de Ribaupierre S; Wöhrer A; Erridge SC; Hegi M; Weller M; Stupp R
    Ann Neurol; 2011 Jul; 70(1):9-21. PubMed ID: 21786296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The intersection between genetic engineering and immunotherapy: taking a BiTE out of glioblastoma.
    Njoku I; Boockvar JA
    Neurosurgery; 2013 Jun; 72(6):N16-7. PubMed ID: 23685511
    [No Abstract]   [Full Text] [Related]  

  • 10. Passive immunotherapeutic strategies for the treatment of malignant gliomas.
    Nagasawa DT; Fong C; Yew A; Spasic M; Garcia HM; Kruse CA; Yang I
    Neurosurg Clin N Am; 2012 Jul; 23(3):481-95. PubMed ID: 22748660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotreatment in patients with glioblastoma multiforme--a histopathological evaluation of reactive and inflammatory changes.
    Persson A; Skagerberg G; Salford LG; Englund E;
    Clin Neuropathol; 2005; 24(5):201-8. PubMed ID: 16167543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of brain tumors.
    Ross IS
    J Med Soc N J; 1972 Jun; 69(6):517-21. PubMed ID: 4338169
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunotherapy of intracranial G422 glioblastoma with dendritic cells pulsed with tumor extract or RNA.
    Zhang Z; Tang LL; Zhan RY; Tong Y; Yao HP; Du LA
    J Zhejiang Univ Sci; 2004 Oct; 5(10):1298-303. PubMed ID: 15362204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower Extremity Edema, Anxiety, and Cyanosis During Chemoradiation Therapy for Glioblastoma.
    Rizk N; Kamiya-Matsuoka C; Tremont-Lukats IW
    JAMA Oncol; 2016 Feb; 2(2):265-6. PubMed ID: 26540389
    [No Abstract]   [Full Text] [Related]  

  • 15. The contenders. Vaccines and viruses take aim at cancer cells.
    Clancy F
    Minn Med; 2005 Apr; 88(4):24-8. PubMed ID: 15940888
    [No Abstract]   [Full Text] [Related]  

  • 16. Solving the riddle of glioblastoma: The hope for immunotherapy.
    Bashir R; Mohile NA
    Neurology; 2016 Jun; 86(24):2220-1. PubMed ID: 27225224
    [No Abstract]   [Full Text] [Related]  

  • 17. How can we trick the immune system into overcoming the detrimental effects of oncolytic viral therapy to treat glioblastoma?
    Meisen WH; Kaur B
    Expert Rev Neurother; 2013 Apr; 13(4):341-3. PubMed ID: 23545048
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune responses in glioblastoma: an avenue to effective cancer therapy or a mere epiphenomenon?
    Schluesener HJ; Meyermann R; Deininger M
    Curr Top Microbiol Immunol; 2002; 265():259-67. PubMed ID: 12014194
    [No Abstract]   [Full Text] [Related]  

  • 19. [The comparison of glioblastoma and its surrounding edema by MRI of brain].
    Stashuk GA; Balkanov AS
    Vestn Rentgenol Radiol; 2006; (3):19-23. PubMed ID: 17407960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autoantibodies in glioblastoma multiforme (author's transl)].
    Roda JE; Heredero JJ; Villarejo FJ; Roda JM
    Arch Neurobiol (Madr); 1980; 43(6):377-90. PubMed ID: 6258534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.